Back to jobs
New

Director, Strategic Analytics and Market Research

Princeton, NJ

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

  • HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

  • HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

  • HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

  • HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Location: Princeton, NJ Onsite

Overview of Role: 

The Director, Strategic Analytics and Market Research will lead integrated market research and forward-looking strategic analytics across Summit’s portfolio of indications. This senior individual contributor will combine primary and secondary research with real-world data to size opportunities, anticipate market evolution, and guide portfolio, launch, and long-range decisions for ivonescimab.  

This role offers broad ownership across priority tumor areas and direct influence on portfolio, launch, and long-range decisions. The successful candidate will help shape Summit’s integrated insights and strategic analytics capability as ivonescimab advances toward commercialization, with regular exposure to senior cross-functional leaders. This is a senior individual-contributor role with broad cross-functional influence and direct exposure to portfolio, launch, and long-range decisions.  

Role and Responsibilities: 

  • Lead integrated market research and strategic analytics across lung and colorectal cancer indications, addressing market evolution, patient opportunity, treatment pathways, competitors, and strategic choices. 
  • Lead primary and secondary research across the product lifecycle, including patient journey, segmentation, positioning, message testing, ATU, share of voice, and HCP, patient, and payer insights. 
  • Integrate claims, EHR, chart, competitive intelligence, social listening, access, and medical evidence for market sizing, segmentation, scenario development, and decision-ready recommendations. 
  • Serve as a thought partner to Forecasting by triangulating market, research, and real-world evidence to inform and challenge assumptions; this role does not own the forecast. 
  • Use enterprise-approved AI tools to accelerate research, synthesis, scenario testing, and patient-identification logic, with appropriate human review, source validation, privacy, and compliance controls. 
  • Partner with Marketing, Forecasting, Market Access, HEOR, Medical Affairs, Business Development, Finance, and Commercial Analytics to support portfolio, launch, and long-range decisions. 
  • Focus on market, indication, patient-segment, treatment-pathway, and competitive-scenario analytics, not field reporting, targeting, dashboards, call planning, or incentive compensation. 
  • Manage vendors, budgets, timelines, and quality while improving speed and cost efficiency and ensuring compliance with regulatory requirements, industry guidelines, privacy obligations, and Summit policies.  

  

Required Experience, Education and Skills: 

  • Advanced degree in Business, Marketing, Life Sciences, Data Science, or a related field, or equivalent experience. 
  • Minimum of 10+ years of pharmaceutical or biotechnology experience in market research, insights, strategic analytics, or related disciplines. 
  • Significant Oncology experience, with strong knowledge of solid-tumor markets (lung & colorectal) 
  • Experience supporting late-stage assets, launch strategy, or in-line Oncology brands. 
  • Expertise in qualitative and quantitative research, market and patient sizing, segmentation, scenario planning, forecast-assumption support, and competitive assessment. 
  • Ability to integrate primary research with claims, EHR, chart, or other real-world evidence and translate complex findings into concise, unbiased recommendations for senior leaders. 
  • Direct experience using claims, EHR, or chart data for strategic decision support. 
  • Demonstrated use of enterprise-approved AI tools to accelerate research design, secondary research, synthesis, or scenario development, with appropriate validation 
  • Strong vendor, project, and budget management skills, with the ability to work broadly and independently in a fast-paced environment.

 

This is the pay for this position

Pay Transparency

$203,000 - $253,000 USD

 

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Create a Job Alert

Interested in building your career at Summit Therapeutics? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Education

Select...
Select...
Select...

Select...
Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Summit Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...